Table 1.
Treatment regimens and the assignment of subjects to each.
| Regimen | Drug treatment | n Female/Male |
|---|---|---|
| A | 800 mg twice daily SQV-SGC | 1/7 |
| B | 400 mg twice daily RTV | 2/6 |
| C | 400 mg twice daily SQV-SGC plus 400 mg twice daily RTV | 2/6 |
| D | 600 mg twice daily SQV-SGC plus 300 mg twice daily RTV | 0/8 |
| E | 800 mg twice daily SQV-SGC plus 200 mg twice daily RTV | 0/8 |
| F | 800 mg twice daily SQV-SGC plus 300 mg twice daily RTV | 1/7 |
| G | 800 mg twice daily SQV-SGC plus 400 mg twice daily RTV | 1/7 |
| H | 600 mg twice daily SQV-SGC plus 400 mg twice daily RTV | 1/7 |